Transcranial Doppler for Internal Carotid Artery Stenting (TCD-ICAS)
NCT: NCT07462546 · RECRUITING
Brief Summary
Carotid artery stenting (CAS) prevents stroke but carries risks of perioperative cerebral embolism. Transcranial Doppler (TCD) ultrasound can detect microemboli during CAS and may offer therapeutic benefits through ultrasound-enhanced thrombolysis. Trials like SONOBUSTER and SONOBIRDIE suggest TCD reduces new brain infarctions during carotid procedures. The TCD-ICAS trial will investigate whether TCD application during and after CAS reduces perioperative cerebral emboli and improves outcomes.
Frequently Asked Questions
What is Transcranial Doppler for Internal Carotid Artery Stenting (TCD-ICAS)?
Transcranial Doppler for Internal Carotid Artery Stenting (TCD-ICAS) is a clinical trial registered under NCT07462546. Current status: RECRUITING.
What is the status of NCT07462546?
The current status of NCT07462546 (Transcranial Doppler for Internal Carotid Artery Stenting (TCD-ICAS)) is: RECRUITING.
When did Transcranial Doppler for Internal Carotid Artery Stenting (TCD-ICAS) start?
Transcranial Doppler for Internal Carotid Artery Stenting (TCD-ICAS) started on 2026-03-24.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.